Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection

Infection and Immunity

Volumn 78, Issue 10, 2010, Pages 4226-4233

  Muñoz, Natalia ^a   Van Maele, Laurye ^b   Marqués, Juan M ^a   Rial, Analía ^a   Sirard, Jean Claude ^b   Chabalgoity, José A ^a  

^a Universidad de la Republica Instituto de Higiene   (Uruguay)

^b UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLAGELLIN; INTERLEUKIN 6; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE RESISTANCE; DRUG MECHANISM; FEMALE; GENE EXPRESSION; INNATE IMMUNITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS PNEUMONIA; SURVIVAL RATE; UPREGULATION;

EID: 77957728392     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00224-10     Document Type: Article

References (45)

1. Albiger, B., A. Sandgren, H. Katsuragi, U. Meyer-Hoffert, K. Beiter, F. Wartha, M. Hornef, S. Normark, and B. H. Normark. 2005. Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice. Cell. Microbiol. 7:1603-1615.
2. -/- mice are more susceptible to Escherichia coli urinary tract infection. J. Immunol. 178:4717-4720.
3. Balloy, V., A. Verma, S. Kuravi, M. Si-Tahar, M. Chignard, and R. Ramphal. 2007. The role of flagellin versus motility in acute lung disease caused by Pseudomonas aeruginosa. J. Infect. Dis. 196:289-296.
4. Beall, B. 2007. Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting. Expert Rev. Vaccines 6:297-301.
5. Ben-David, I., S. E. Price, D. M. Bortz, C. F. Greineder, S. E. Cohen, A. L. Bauer, T. L. Jackson, and J. G. Younger. 2005. Dynamics of intrapulmonary bacterial growth in a murine model of repeated microaspiration. Am. J. Respir. Cell Mol. Biol. 33:476-482.
6. Brown, K. L., C. Cosseau, J. L. Gardy, and R. E. Hancock. 2007. Complexities of targeting innate immunity to treat infection. Trends Immunol. 28:260-266.
7. Clement, C. G., S. E. Evans, C. M. Evans, D. Hawke, R. Kobayashi, P. R. Reynolds, S. J. Moghaddam, B. L. Scott, E. Melicoff, R. Adachi, B. F. Dickey, and M. J. Tuvim. 2008. Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice. Am. J. Respir. Crit. Care Med. 177:1322-1330.
8. Craig, A., J. Mai, S. Cai, and S. Jeyaseelan. 2009. Neutrophil recruitment to the lungs during bacterial pneumonia. Infect. Immun. 77:568-575.
9. Empey, K. M., M. Hollifield, and B. A. Garvy. 2007. Exogenous heat-killed Escherichia coli improves alveolar macrophage activity and reduces Pneumocystis carinii lung burden in infant mice. Infect. Immun. 75:3382-3393.
10. Feuillet, V., S. Medjane, I. Mondor, O. Demaria, P. P. Pagni, J. E. Galán, R. A. Flavell, and L. Alexopoulou. 2006. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc. Natl. Acad. Sci. U. S. A. 103:12487-12492.
11. Franchi, L., A. Amer, M. Body-Malapel, T. D. Kanneganti, N. Ozoren, R. Jagirdar, N. Inohara, P. Vandenabeele, J. Bertin, A. Coyle, E. P. Grant, and G. Nunez. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages. Nat. Immunol. 7:576-582.
12. Haas, K. M., J. C. Poe, D. A. Steeber, and T. F. Tedder. 2005. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23:7-18.
13. Hayashi, F., T. K. Means, and A. D. Luster. 2003. Toll-like receptors stimulate human neutrophil function. Blood 102:2660-2669.
14. Hayashi, F., K. D. Smith, A. Ozinsky, T. R. Hawn, E. C. Yi, D. R. Goodlett, J. K. Eng., S. Akira, D. M. Underhill, and A. Aderem. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410:1099-1103.
15. Honko, A. N., and S. B. Mizel. 2004. Mucosal administration of flagellin induces innate immunity in the mouse lung. Infect. Immun. 72:6676-6679.
16. Janot, L., J. C. Sirard, T. Secher, N. Noulin, L. Fick, S. Akira, S. Uematsu, A. Didierlaurent, T. Hussell, B. Ryffel, and F. Erard. 2009. Radioresistant cells expressing TLR5 control the respiratory epithelium's innate immune responses to flagellin. Eur. J. Immunol. 39:1587-1596.
17. Kadioglu, A., W. Coward, M. J. Colston, C. R. Hewitt, and P. W. Andrew. 2004. CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection. Infect. Immun. 72:2689-2697.
18. Kadioglu, A., N. A. Gingles, K. Grattan, A. Kerr, T. J. Mitchell, and P. W. Andrew. 2000. Host cellular immune response to pneumococcal lung infection in mice. Infect. Immun. 68:492-501.
19. Käyhty, H., K. Auranen, H. Nohynek, R. Dagan, and H. Makela. 2006. Nasopharyngeal colonization: a target for pneumococcal vaccination. Expert Rev. Vaccines 5:651-667.
20. Khan, A. Q., Q. Chen, Z.-Q. Wu, J. C. Paton, and C. M. Snapper. 2005. Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on Toll-like receptor 2. Infect. Immun. 73:298-307.
21. Lembo, A., M. Pelletier, R. Iyer, M. Timko, J. C. Dudda, T. E. West, C. B. Wilson, A. M. Hajjar, and S. J. Skerrett. 2008. Administration of a synthetic TLR4 agonist protects mice from pneumonic tularemia. J. Immunol. 180:7574-7581.
22. Lysenko, E. S., T. B. Clarke, M. Shchepetov, A. J. Ratner, D. I. Roper, C. G. Dowson, and J. N. Weiser. 2007. Nod1 signaling overcomes resistance of S. pneumoniae to opsonophagocytic killing. PLoS Pathog. 3:e118.
23. Lysenko, E. S., A. J. Ratner, A. L. Nelson, and J. N. Weiser. 2005. The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog. 1:e1.
24. Marks, M., T. Burns, M. Abadi, B. Seyoum, J. Thornton, E. Tuomanen, and L.-A. Pirofski. 2007. Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice. Infect. Immun. 75:1586-1597.
25. Miao, E. A., C. M. Alpuche-Aranda, M. Dors, A. E. Clark, M. W. Bader, S. I. Miller, and A. Aderem. 2006. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf. Nat. Immunol. 7:569-575.
26. Miao, E. A., D. P. Mao, N. Yudkovsky, R. Bonneau, C. G. Lorang, S. E. Warren, I. A. Leaf, and A. Aderem. 2010. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. U. S. A. 107:3076-3080.
27. Nempont, C., D. Cayet, M. Rumbo, C. Bompard, V. Villeret, and J. C. Sirard. 2008. Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity. J. Immunol. 181:2036-2043.
28. Normark, B. H., and S. Normark. 2002. Evolution and spread of antibiotic resistance. J. Intern. Med. 252:91-106.
29. Opitz, B., A. Puschel, B. Schmeck, A. C. Hocke, S. Rosseau, S. Hammerschmidt, R. R. Schumann, N. Suttorp, and S. Hippenstiel. 2004. Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J. Biol. Chem. 279:36426-36432.
30. Oshikawa, K., and Y. Sugiyama. 2003. Gene expression of Toll-like receptors and associated molecules induced by inflammatory stimuli in the primary alveolar macrophage. Biochem. Biophys. Res. Commun. 305:649-655.
31. Perry, F. E., C. J. Elson, T. J. Mitchell, P. W. Andrew, and J. R. Catterall. 1994. Characterisation of an oxidative response inhibitor produced by Streptococcus pneumoniae. Thorax 49:676-683.
32. Prince, A. 2006. Flagellar activation of epithelial signaling. Am. J. Respir. Cell Mol. Biol. 34:548-551.
33. Ramos, H. C., M. Rumbo, and J. C. Sirard. 2004. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol. 12:509-517.
34. Rial, A., D. Lens, L. Betancor, H. Benkiel, J. S. Silva, and J. A. Chabalgoity. 2004. Intranasal immunization with a colloid-formulated bacterial extract induces an acute inflammatory response in the lungs and elicits specific immune responses. Infect. Immun. 72:2679-2688.
35. Romagne, F. 2007. Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors. Drug Discov. Today 12:80-87.
36. Salyers, A. A., and D. D. Whitt. 2002. Bacterial pathogenesis: a molecular approach, 2nd ed. ASM Press, Washington, DC.
37. Sha, Q., A. Q. Truong-Tran, J. R. Plitt, L. A. Beck, and R. P. Schleimer. 2004. Activation of airway epithelial cells by toll-like receptor agonists. Am. J. Respir. Cell Mol. Biol. 31:358-364.
38. Sierro, F., B. Dubois, A. Coste, D. Kaiserlian, J. P. Kraehenbuhl, and J. C. Sirard. 2001. Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 98:13722-13727.
39. Tomasz, A., A. Corso, E. P. Severina, G. Echániz-Aviles, M. C. Brandileone, T. Camou, E. Castaneda, O. Figueroa, A. Rossi, and J. L. Di Fabio. 1998. Molecular epidemiologic characterization of penicillin-resistant Streptococcus pneumoniae invasive pediatric isolates recovered in six Latin-American countries: an overview. PAHO/Rockefeller University Workshop. Pan American Health Organization. Microb. Drug Resist. 4:195-207.
40. U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases. May 2007. The Jordan report: accelerated development of vaccines 2007. NIH publication 06-6057. http://www.niaid.nih.gov/about/organization/dmid/Documents/jordan2007. pdf.
41. Van Bambeke, F., R. R. Reinert, P. C. Appelbaum, P. M. Tulkens, and W. E. Peetermans. 2007. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options. Drugs 67:2355-2382.
42. van der Poll, T., and S. M. Opal. 2009. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374:1543-1556.
43. von Bernuth, H., C. Picard, Z. Jin, R. Pankla, H. Xiao, C. L. Ku, M. Chrabieh, I. B. Mustapha, P. Ghandil, Y. Camcioglu, J. Vasconcelos, N. Sirvent, M. Guedes, A. B. Vitor, M. J. Herrero-Mata, J. I. Arostegui, C. Rodrigo, L. Alsina, E. Ruiz-Ortiz, M. Juan, C. Fortuny, J. Yague, J. Anton, M. Pascal, H. H. Chang, L. Janniere, Y. Rose, B. Z. Garty, H. Chapel, A. Issekutz, L. Marodi, C. Rodriguez-Gallego, J. Banchereau, L. Abel, X. Li, D. Chaussabel, A. Puel, and J. L. Casanova. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321:691-696.
44. WHO. 2007. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly. Epidemiol. Rec. 82:93-104.
45. Zhang, X., L. Majlessi, E. Deriaud, C. Leclerc, and R. Lo-Man. 2009. Coactivation of Syk kinase and MyD88 adaptor protein pathways by bacteria promotes regulatory properties of neutrophils. Immunity 31:761-771.